Sunrest Lifescience Approves Rights Issue to Raise Up To Rs. 15.10 Crores from Shareholders
Sunrest Lifescience Limited has approved a rights issue for its existing shareholders as part of a strategic move to raise funds. The decision was taken by the Board of Directors during a meeting held on June 26, 2026.The company’s board transacted and approved the raising of funds through the issuance of fully paid-up equity shares on a rights basis. This initiative is designed to pool capital, with the target amount aggregating up to Rs.15.10 crores (Rupees Fifteen Crore Ten Lakh Only).
In line with the approval, details regarding the securities being issued have been finalized. The issuance involves Fully Paid up Equity Shares, each having a face value of Rs.10/-. This right issue is extended to existing equity shareholders of Sunrest Lifescience Limited.
The core aspects of the proposed rights issue are detailed below:
| Particulars | Details |
|---|---|
| Type of Securities Proposed | Fully Paid up Equity Shares having face value of Rs.10/- each. |
| Nature of Issuance | Right issue to the existing Shareholders. |
| Total Amount Targeted | Up to Rs.15.10 crores (Rupees Fifteen Crore Ten Lakh Only). |
The approval covers the entire matter, including all other business items as circulated in the agenda for the Board meeting held on June 26, 2026.
SUNREST Stock Price Movement
On Thursday, shares of Sunrest Lifescience Limited settled flatly in the market session, closing at ₹35.05 after posting a zero percent change. The equity maintained its previous day's price, indicating stability and no significant movement across the trading period.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.